Cargando…

Correlations Between Awareness of Illness (Insight) and History of Addiction in Heroin-Addicted Patients

In a group of 1066 heroin addicts, who were seeking treatment for opioid agonist treatment, we looked for differences in historical, demographic, and clinical characteristics, between patients with different levels of awareness of illness (insight). The results showed that, in the cohort studied, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maremmani, Angelo Giovanni Icro, Rovai, Luca, Rugani, Fabio, Pacini, Matteo, Lamanna, Francesco, Bacciardi, Silvia, Perugi, Giulio, Deltito, Joseph, Dell’Osso, Liliana, Maremmani, Icro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391664/ https://www.ncbi.nlm.nih.gov/pubmed/22787450 http://dx.doi.org/10.3389/fpsyt.2012.00061

Ejemplares similares

Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry
por: Maremmani, Icro, et al.
Publicado: (2012)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Symptomatological Features of Patients with and without Ecstasy Use during Their First Psychotic Episode
por: Rugani, Fabio, et al.
Publicado: (2012)

Can Ropinirole Modulate Reinforcing Subjective Effects of Cocaine in Humans?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Clonazepam as Agonist Substitution Treatment for Benzodiazepine Dependence: A Case Report
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2013)

The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'?
por: Maremmani, Icro, et al.
Publicado: (2007)

Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
por: Maremmani, Icro, et al.
Publicado: (2010)

Six-Month Outcome in Bipolar Spectrum Alcoholics Treated with Acamprosate after Detoxification: A Retrospective Study
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2014)

Further Evidence of a Specific Psychopathology of Addiction. Differentiation from Other Psychiatric Psychopathological Dimensions (Such as Obesity)
por: Maremmani, Angelo G.I., et al.
Publicado: (2017)

The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Long-Term γ-Hydroxybutyric Acid (GHB) and Disulfiram Combination Therapy in GHB Treatment-Resistant Chronic Alcoholics
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
por: Maremmani, Angelo G. I., et al.
Publicado: (2018)

Toward the Identification of a Specific Psychopathology of Substance Use Disorders
por: Maremmani, Angelo G. I., et al.
Publicado: (2017)

Characteristics of Stress Sensitivity in Heroin Use Disorder Patients during Their Opioid Agonist Treatment
por: Della Rocca, Filippo, et al.
Publicado: (2023)

What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients
por: Maremmani, Angelo G.I., et al.
Publicado: (2019)

Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment
por: Pani, Pier Paolo, et al.
Publicado: (2014)

Gender Differences in the Relationship between Maladaptive Behaviors and Post-Traumatic Stress Disorder. A Study on 900 L’ Aquila 2009 Earthquake Survivors
por: Dell’Osso, Liliana, et al.
Publicado: (2013)

Erratum to: Agonist Opioid Treatment as historical comprehensive treatment (‘Dole & Nyswander’ methodology) is associated with better toxicology outcome than Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2017)

The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment
por: Bizzarri, Jacopo V., et al.
Publicado: (2016)

Delineating the Psychic Structure of Substance Use and Addictions, from Neurobiology to Clinical Implications: Ten Years Later
por: Pani, Pier Paolo, et al.
Publicado: (2020)

Anti-AMPA-Receptor Encephalitis Presenting as a Rapid-Cycling Bipolar Disorder in a Young Woman with Turner Syndrome
por: Quaranta, Giuseppe, et al.
Publicado: (2015)

The Conceptual Framework of Dual Disorders and Its Flaws
por: Pacini, Matteo, et al.
Publicado: (2020)

Remarkable Reduction of Cocaine Use in Dual Disorder (Adult Attention Deficit Hyperactive Disorder/Cocaine Use Disorder) Patients Treated with Medications for ADHD
por: Manni, Corrado, et al.
Publicado: (2019)

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
por: Maremmani, Angelo G. I., et al.
Publicado: (2021)

Substance Use/Dependence in Psychiatric Emergency Setting Leading to Hospitalization: Predictors of Continuity of Care
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2022)

Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features
por: Spera, Vincenza, et al.
Publicado: (2020)

Does Cannabis, Cocaine and Alcohol Use Impact Differently on Adult Attention Deficit/Hyperactivity Disorder Clinical Picture?
por: Spera, Vincenza, et al.
Publicado: (2021)

Symptomatological Variants and Related Clinical Features in Adult Attention Deficit Hyperactive Disorder
por: Pallucchini, Alessandro, et al.
Publicado: (2021)

Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician
por: Barbuti, Margherita, et al.
Publicado: (2023)

Exploring the Role of Caffeine Use in Adult-ADHD Symptom Severity of US Army Soldiers
por: Cipollone, Giada, et al.
Publicado: (2020)

Could Temperamental Features Modulate Participation in Clinical Trials?
por: Cintoli, Simona, et al.
Publicado: (2023)

Adult separation anxiety in patients with complicated grief versus healthy control subjects: relationships with lifetime depressive and hypomanic symptoms
por: Dell'Osso, Liliana, et al.
Publicado: (2011)

Psychiatric Symptoms in Patients with Cerebral Endometriosis: A Case Report and Literature Review
por: Elefante, Camilla, et al.
Publicado: (2022)

Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
por: Lovrecic, Barbara, et al.
Publicado: (2019)

Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology
por: Weiss, Francesco, et al.
Publicado: (2020)

Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
por: Pani, Pier Paolo, et al.
Publicado: (2016)

Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease
por: Elefante, Camilla, et al.
Publicado: (2021)

Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice
por: Clerici, Massimo, et al.
Publicado: (2018)

Addictive and other mental disorders: a call for a standardized definition of dual disorders
por: Szerman, Nestor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vvk2jdn5nuic3ipa41a4kkcavm